6.38

7.77% 0.46

Pre-market: 6.61 0.23 +3.61%

Intensity Therapeutics Inc (INTS)

Overview News Price History Financials Why INTS Down? Discussions Forecast

Intensity Therapeutics Inc stock is traded at $6.38, with a volume of 29,420. It is up +7.77% in the last 24 hours and down -10.39% over the past month. Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Previous Close:

$5.92

Open:

$6.08

24h Volume:

29,420

Relative Volume:

0.54

Market Cap:

$16.17M

Revenue:

Net Income/Loss:

$-11.74M

P/E Ratio:

-0.6036

EPS:

-10.5698

Net Cash Flow:

$-9.50M

1W Performance:

-1.54%

1M Performance:

-10.39%

6M Performance:

+2.90%

1Y Performance:

-87.43%

1-Day Range:

$5.8379

$6.38

1-Week Range:

$5.7895

$6.39

52-Week Range:

$4.6325

$52.25

Intensity Therapeutics Inc Stock (INTS) Company Profile

Name

Intensity Therapeutics Inc

Sector

Healthcare (1114)

Industry

Biotechnology (623)

Phone

203-221-7381

Address

1 ENTERPRISE DRIVE, SUITE 430, SHELTON

Employee

Twitter

Next Earnings Date

2026-03-26

Latest SEC Filings

INTS's Discussions on Twitter

Compare INTS vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INTS Intensity Therapeutics Inc	6.38	16.17M	0	-11.74M	-9.50M	-10.57
VRTX Vertex Pharmaceuticals Inc	454.97	115.58B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	79.23B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	43.59B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	43.26B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	31.97B	606.42M	-1.28B	-997.58M	-6.403

Intensity Therapeutics Inc Stock (INTS) Latest News

Mar 25, 2026

US Market Recap: Does Intensity Therapeutics Inc have strong EBITDA margins2026 Sector Moves & Verified Momentum Watchlists - baoquankhu1.vn

Mar 25, 2026

Intensity Therapeutics receives new US patent for cancer treatment By Investing.com - Investing.com Australia

Mar 25, 2026

Mar 24, 2026

Intensity Therapeutics issued new patent in the US - TipRanks

Mar 24, 2026

Intensity Therapeutics receives new US patent for cancer treatment - Investing.com

Mar 24, 2026

Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US - ChartMill

Mar 24, 2026

Mar 23, 2026

Intensity Therapeutics Inc increases ATM offering capacity to $60 million on March 23, 2026SEC filing - marketscreener.com

Mar 23, 2026

Intensity Therapeutics IncIncreases ATM Offering Capacity To $60 Million On March 23, 2026SEC Filing - TradingView

Mar 23, 2026

Intensity Therapeutics Expands ATM Equity Offering Capacity - TipRanks

Mar 23, 2026

Intensity Therapeutics boosts ATM capacity to $60.0M to enhance financing flexibility - TradingView

Mar 23, 2026

Intensity Therapeutics (NASDAQ: INTS) boosts $60M at-the-market capacity - Stock Titan

Mar 23, 2026

Intensity Therapeutics (NASDAQ: INTS) raises ATM capacity to $60M - Stock Titan

Mar 23, 2026

Mar 22, 2026

If You Invested $1,000 in INTENSITY THERAPEUTICS INC (INTS) - Stock Titan

Mar 22, 2026

Is Intensity Therapeutics Inc currently under institutional pressure2026 Trends & High Win Rate Trade Tips - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

Block Trades: Is Intensity Therapeutics Inc currently under institutional pressureWeekly Market Outlook & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Mar 21, 2026

Technical Analysis: Is Intensity Therapeutics Inc stock a top performer YTD2026 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Aug Rallies: Should I set a stop loss on Intensity Therapeutics Inc2026 Rallies & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Mar 20, 2026

INTS Stock Price, Quote & Chart | INTENSITY THERAPEUTICS INC (NASDAQ:INTS) - ChartMill

Mar 20, 2026

Mar 18, 2026

Forecast Cut: Can Intensity Therapeutics Inc ride the EV waveWeekly Profit Analysis & Technical Entry and Exit Alerts - baoquankhu1.vn

Mar 18, 2026

Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement - MSN

Mar 18, 2026

Mar 17, 2026

Intensity Therapeutics reports early trial data in breast cancer - Investing.com Nigeria

Mar 17, 2026

Mar 16, 2026

Intensity Therapeutics updates breast cancer trial, files to resume enrollment following study pause - MSN

Mar 16, 2026

Mar 14, 2026

Intensity Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Nigeria

Mar 14, 2026

Alliance Global Partners Sticks to Their Buy Rating for Intensity Therapeutics, Inc. (INTS) - The Globe and Mail

Mar 14, 2026

Mar 13, 2026